Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria

• Published in: The Journal of immunology (1950) Vol. 190; no. 9; pp. 4685 - 4691
• Main Authors: Aggrey, Angela A, Srivastava, Kalyan, Ture, Sara, Field, David J, Morrell, Craig N
• Format: Journal Article
• Language: English
• Published: United States 01-05-2013
• Subjects: Acute-Phase Reaction - immunology; Animals; Blood Platelets - immunology; Disease Models, Animal; Malaria - blood; Malaria - immunology; Malaria, Cerebral - blood; Malaria, Cerebral - immunology; Mice; Mice, Inbred C57BL; Plasmodium; Plasmodium berghei; Platelet Activation - immunology
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.1202672

Platelets are most recognized as the cellular mediator of thrombosis, but they are increasingly appreciated for their immunomodulatory roles, including responses to Plasmodium infection. Platelet interactions with endothelial cells and leukocytes contribute significantly to the pathogenesis of experimental cerebral malaria (ECM). Recently, it has been suggested that platelets not only have an adverse role in cerebral malaria, but platelets may also be protective in animal models of uncomplicated malaria. We now demonstrate that these diverse and seemingly contradictory roles for platelets extend to cerebral malaria models and are dependent on the timing of platelet activation during infection. Our data show that platelets are activated very early in ECM and have a central role in initiation of the acute-phase response to blood-stage infection. Unlike platelet depletion or inhibition postinfection, preinfection platelet depletion or treatment with a platelet inhibitor is not protective. Additionally, we show that platelet-driven acute-phase responses have a major role in protecting mice from ECM by limiting parasite growth. Our data now suggest that platelets have a complex role in ECM pathogenesis: platelets help limit parasite growth early postinfection, but with continued platelet activation as the disease progresses, platelets contribute to ECM-associated inflammation.